News blog

Angel Biotechnology Holdings

  • BY: Andrew Hore |
  • POSTED: 12/02/2011 |

Biopharmaceutical contract manufacturer Angel Biotechnology Holdings has signed a five year pricing agreement with Russian pharma company Materia Medica who could award further contracts worth more than £4.5m.

Angel expects to sign at least three more contracts with Materia Medica, which has previously signed six contracts with Angel. The pricing agreement makes the cost of the services predictable for Materia Medica.

The additional contracts will provide further business for the new manufacturing facility that Angel plans to unveil in the coming weeks. 

At 0.5p a share, Angel is valued at £13.4m.

© 2024 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds